Search - tctmd.com

Displaying 361 - 380 of 1585

Sort: Relevancy | Date

Presentation NY Valves 2025

Laplace TTVR System: EFS Update

Presenter: Brandon M. Jones

June 26, 2025

Presentation NY Valves 2025

Zero-Exchange Transseptal Puncture Devices Improve Procedural Workflow and Consistency During Left Atrial Appendage Closure

Presenter: Joseph R. Aragon

June 26, 2025

Presentation NY Valves 2025

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Presenter: Ogechukwu Samuel Obi

June 26, 2025

Presentation NY Valves 2025

Best Practices for Choosing Amulet Occluder Size for Optimal Outcomes

Presenter: Jacqueline Saw

June 26, 2025

Presentation NY Valves 2025

Peri-Device Leak Management After Watchman FLX Device Malapposition

Presenter: Yashasvi Chugh

June 26, 2025

Presentation NY Valves 2025

Fluro Before You Close: Usage of Multi-Modality Imaging to Guide Closure of Mitral Para-Valvular Leak

Presenter: Armaghan Soomro

June 26, 2025

Presentation NY Valves 2025

Case 2: Severe AS and Severe MR

Presenter: Joanna Bartkowiak

June 26, 2025

Presentation NY Valves 2025

Trisol TTVR System: EFS Update

Presenter: Vinod H. Thourani

June 26, 2025

Presentation NY Valves 2025

From Inside the LV: ANCORA Updates

Presenter: Ulrich P. Jorde

June 26, 2025

Presentation NY Valves 2025

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Presenter: Paul A. Grayburn

June 26, 2025

Presentation NY Valves 2025

Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Tamari Lomaia

June 26, 2025

Presentation NY Valves 2025

3D Intracardiac Echocardiography (ICE) Enables Safe and Effective LAAO Guidance: A Propensity-Matched Comparison With 2D ICE

Presenter: Agata Sularz

June 26, 2025

Presentation NY Valves 2025

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

Presenter: Jadon Ray Rajagopal

June 26, 2025

Presentation NY Valves 2025

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

Presenter: Gagan D. Singh

June 26, 2025

Presentation NY Valves 2025

Migrated Left Atrial Appendage Occlusion Device, Treated by Removal and Placement of New Device

Presenter: Ahmed AlBadri

June 26, 2025

Presentation NY Valves 2025

Case Presentation: 65 year old Woman with Symptomatic HFrEF Refractory to Optimal GDMT

Presenter: Ilan Richter

June 26, 2025

Presentation NY Valves 2025

Topaz TTVR System: EFS and EU PIVOTAL Study Results

Presenter: Pradeep K. Yadav

June 26, 2025

Presentation NY Valves 2025

Zero-fluoroscopy Left Atrial Appendage Occlusion With the Watchman FLX Device

Presenter: Tarun Chakravarty

June 26, 2025

Presentation NY Valves 2025

The Ottawa Mobile Screening Program: Concept and First 18 Months Experience of a Community-Based Out-Reach Cardiovascular Prevention Program

Presenter: David Messika-Zeitoun

June 26, 2025

Presentation NY Valves 2025

Practical Guide to Prevention and Management of LAAC Complications

Presenter: Marek Grygier

June 26, 2025

Advertisement

Laplace TTVR System: EFS Update

Zero-Exchange Transseptal Puncture Devices Improve Procedural Workflow and Consistency During Left Atrial Appendage Closure

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Best Practices for Choosing Amulet Occluder Size for Optimal Outcomes

Peri-Device Leak Management After Watchman FLX Device Malapposition

Fluro Before You Close: Usage of Multi-Modality Imaging to Guide Closure of Mitral Para-Valvular Leak

Case 2: Severe AS and Severe MR

Trisol TTVR System: EFS Update

From Inside the LV: ANCORA Updates

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

3D Intracardiac Echocardiography (ICE) Enables Safe and Effective LAAO Guidance: A Propensity-Matched Comparison With 2D ICE

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

Migrated Left Atrial Appendage Occlusion Device, Treated by Removal and Placement of New Device

Case Presentation: 65 year old Woman with Symptomatic HFrEF Refractory to Optimal GDMT

Topaz TTVR System: EFS and EU PIVOTAL Study Results

Zero-fluoroscopy Left Atrial Appendage Occlusion With the Watchman FLX Device

The Ottawa Mobile Screening Program: Concept and First 18 Months Experience of a Community-Based Out-Reach Cardiovascular Prevention Program

Practical Guide to Prevention and Management of LAAC Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content